FDA Inspection 1244430 — Koichi Goto, M.D.

Koichi Goto, M.D. — FEI 3030842622

The FDA completed an inspection of Koichi Goto, M.D. on Jul 19, 2024 in Kashiwa. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 19, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Kashiwa (Japan)

Additional Details

Clinical Investigator (CI)